Christopher Parrish
- Hematology top 5%
- Multiple Myeloma Research and Treatments 24
- Oncology top 10%
- Cancer Treatment and Pharmacology 8
- CAR-T cell therapy research 5
-
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 4
- Genetics top 10%
- Virus-based gene therapy research 9
-
- Cancer Research and Treatments 6
-
- Protein Degradation and Inhibitors 9
- Co-authors
- Gordon CookAlan MelcherMatt CoffeyGina B. ScottElizabeth J. IlettRichard G. VileHardev PandhaKevin J. Harrington
- Cited by
- HematologyOncologyImmunology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Christopher Parrish
38 papers receiving 686 citations
Peers
Comparison fields: 5 of 75
- Hematology 319
- Oncology 364
- Immunology 187
- Genetics 199
- Biotechnology 46
Countries citing papers authored by Christopher Parrish
This map shows the geographic impact of Christopher Parrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Parrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Parrish more than expected).
Fields of papers citing papers by Christopher Parrish
This network shows the impact of papers produced by Christopher Parrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Parrish. The network helps show where Christopher Parrish may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher Parrish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 10 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 12 | |
| 11 | 2016 | 6 | |
| 12 | 2015 | 154 | |
| 13 | 2015 | 22 | |
| 14 | 2015 | 6 | |
| 15 | 2015 | 32 | |
| 16 | 2014 | 11 | |
| 17 | 2014 | 1 | |
| 18 | 2012 | 63 | |
| 19 | 2009 | 26 | |
| 20 | 2003 | 26 |
About Christopher Parrish
Christopher Parrish is a scholar working on Hematology, Oncology, Biotechnology, Immunology and Genetics, having authored 42 papers that have together received 698 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Immunotherapy and Immune Responses (10 papers), Virus-based gene therapy research (9 papers), Protein Degradation and Inhibitors (9 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Research and Treatments (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Hematology (319 citations), Oncology (364 citations), Immunology (187 citations), Genetics (199 citations) and Biotechnology (46 citations). Christopher Parrish has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Gordon Cook, Alan Melcher, Matt Coffey, Gina B. Scott, Elizabeth J. Ilett, Richard G. Vile, Hardev Pandha, Kevin J. Harrington, Kevin G. Shim and Jill Thompson. Their work appears in journals such as Blood, Molecular Therapy, British Journal of Haematology, Leukemia and The Lancet Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.